Jul 22, 2022
Jul 15, 2022
Jul 1, 2022
New VA Storefront Support Program: Bringing trials to even more VAs
Jun 24, 2022
Jun 17, 2022
The first issue of the SWOG Latin America Initiative (SLAI) Newsletter is out!
Jun 17, 2022
Jun 3, 2022
Ramucirumab plus pembrolizumab combination reduced risk of death by 31 percent compared to standard of care in patients with advanced non-small cell lung cancer that had progressed on prior immunotherapy.
